FY2025 · period end Dec '25 · from the 10-K filed Feb 12, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.66B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001093557-26-000105 | May 27, 2026 | May 28, 2026 | May 28, 2026 21:15 UTC | EDGAR |
| 8-K | 0001093557-26-000085 | May 14, 2026 | May 15, 2026 | May 14, 2026 23:31 UTC | EDGAR |
| 8-K | 0001093557-26-000072 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 20:02 UTC | EDGAR |
| 10-Q | 0001093557-26-000073 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 21:20 UTC | EDGAR |
| 8-K | 0001093557-26-000038 | Feb 27, 2026 | Mar 2, 2026 | Mar 2, 2026 21:15 UTC | EDGAR |
| 8-K | 0001093557-26-000031 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 21:15 UTC | EDGAR |
| 8-K | 0001093557-26-000025 | Feb 12, 2026 | Feb 12, 2026 | Feb 12, 2026 21:03 UTC | EDGAR |
| 10-K | 0001093557-26-000027 | Dec 31, 2025 | Feb 12, 2026 | Feb 12, 2026 22:20 UTC | EDGAR |
Direct links to SEC EDGAR. DXCM has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q1 2021
Major restatementwas$21.2M
Revised up in a 10-Q.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2021
Major restatementwas$173.9M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·FY 2021
Major restatementwas$154.7M
Revised up. Any P/E built on the original was 28.7% too high.
Net Income (Loss) Attributable to Parent·Q1 2021
Major restatementwas$40.3M
Revised up in a 10-Q. Any P/E built on the original was 28.7% too high.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2021
Major restatementwas$235.3M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2020
Major restatementwas$225M
Revised up in a 10-K.
DXCM is not the only one.
See every restatement we've found across the market — or get an alert the next time DXCM revises a number.
Restatements are detected by comparing every vintage of a fact across all of DEXCOM INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows DXCM's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling DEXCOM INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on DXCM yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on DXCM and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $3.62B |
| $2.91B |
| $2.45B |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B |
|---|
| Operating Income | $0.91B | $0.60B | $0.60B | $0.39B | $0.27B |
|---|
| Net Income | $0.84B | $0.58B | $0.54B | $0.34B | $0.22B |
|---|
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B |
| Cash & Equivalents | $0.92B | $0.61B | $0.57B | $0.64B | $1.05B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.44B | $0.99B | $0.75B | $0.67B | $0.44B |
| Capital Expenditures | $0.36B | $0.36B | $0.24B | $0.36B | $0.39B |
| Free Cash Flow | $1.08B | $0.63B | $0.51B | $0.30B | $0.05B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating Margin | 0.2% | 0.1% | 0.2% | 0.1% | 0.1% |
| Net Margin | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 34.5% | 27.6% | 25.8% | 16.3% | 11.2% |
| Return on Assets | 13.0% | 9.0% | 9.3% | 6.6% | 4.7% |
| Debt / Equity | — | — | — | — | — |
